IL112897A0 - Aerosol drug formulations containing vitamin e - Google Patents

Aerosol drug formulations containing vitamin e

Info

Publication number
IL112897A0
IL112897A0 IL11289795A IL11289795A IL112897A0 IL 112897 A0 IL112897 A0 IL 112897A0 IL 11289795 A IL11289795 A IL 11289795A IL 11289795 A IL11289795 A IL 11289795A IL 112897 A0 IL112897 A0 IL 112897A0
Authority
IL
Israel
Prior art keywords
formulations containing
drug formulations
containing vitamin
aerosol drug
aerosol
Prior art date
Application number
IL11289795A
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of IL112897A0 publication Critical patent/IL112897A0/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/12Aerosols; Foams
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/3533,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355Tocopherols, e.g. vitamin E
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL11289795A 1994-03-14 1995-03-06 Aerosol drug formulations containing vitamin e IL112897A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US21247294A 1994-03-14 1994-03-14

Publications (1)

Publication Number Publication Date
IL112897A0 true IL112897A0 (en) 1995-06-29

Family

ID=22791169

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11289795A IL112897A0 (en) 1994-03-14 1995-03-06 Aerosol drug formulations containing vitamin e

Country Status (7)

Country Link
EP (1) EP0804157A1 (en)
JP (1) JPH09510445A (en)
KR (1) KR970701535A (en)
AU (1) AU709783B2 (en)
CA (1) CA2183557A1 (en)
IL (1) IL112897A0 (en)
WO (1) WO1995024892A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9409778D0 (en) 1994-05-16 1994-07-06 Dumex Ltd As Compositions
EP0914143A1 (en) * 1996-07-08 1999-05-12 Rhone-Poulenc Rorer Limited Medicinal cyclosporin-a aerosol solution formulation
US6458373B1 (en) 1997-01-07 2002-10-01 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
US6193954B1 (en) 1997-03-21 2001-02-27 Abbott Laboratories Formulations for pulmonary delivery of dopamine agonists
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
US7030155B2 (en) 1998-06-05 2006-04-18 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
TWI324518B (en) 2001-12-19 2010-05-11 Nektar Therapeutics Pulmonary delivery of aminoglycosides
DE102006051512A1 (en) 2005-12-06 2007-06-14 Pari GmbH Spezialisten für effektive Inhalation Pharmaceutical drug compositions with cyclosporin

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9024365D0 (en) * 1990-11-09 1991-01-02 Glaxo Group Ltd Medicaments
EP0504112A3 (en) * 1991-03-14 1993-04-21 Ciba-Geigy Ag Pharmaceutical aerosol formulations
ATE246497T1 (en) * 1991-06-10 2003-08-15 Schering Corp HYDROCHLOROFLUOROCARBON-FREE AEROSOL FORMULATIONS
EP0518601A1 (en) * 1991-06-10 1992-12-16 Schering Corporation Non-chlorofluorocarbon aerosol formulations
EP0616525B1 (en) * 1991-12-12 1995-09-27 Glaxo Group Limited Pharmaceutical aerosol formulation
ATE204743T1 (en) * 1991-12-18 2001-09-15 Minnesota Mining & Mfg AEROSOL COMPOSITIONS FOR MEDICINAL SUSPENSIONS
DE4203306A1 (en) * 1992-02-06 1993-08-12 Ig Spruehtechnik Gmbh ASTHMA OR PULMONAL AEROSOL PREPARATIONS WITH LECITHIN
US5301664A (en) * 1992-03-06 1994-04-12 Sievers Robert E Methods and apparatus for drug delivery using supercritical solutions
DE4230876A1 (en) * 1992-03-17 1993-09-23 Asta Medica Ag COMPRESSED GAS PACKS USING POLYOXYETHYLENE GLYCERYL OLEATES

Also Published As

Publication number Publication date
AU709783B2 (en) 1999-09-09
EP0804157A1 (en) 1997-11-05
WO1995024892A1 (en) 1995-09-21
KR970701535A (en) 1997-04-12
AU1980495A (en) 1995-10-03
JPH09510445A (en) 1997-10-21
MX9604004A (en) 1997-12-31
CA2183557A1 (en) 1995-09-21

Similar Documents

Publication Publication Date Title
IL116460A0 (en) Aerosol drug formulations
EG23826A (en) Pharmaceutical formulations
GB9408117D0 (en) Pharmaceutical formulations
GB9612297D0 (en) Medicinal aerosol formulations
ZA921877B (en) Pharmaceutical aerosol formulations
GB9523752D0 (en) Pharmaceutical formulations
ZA914957B (en) Aerosol drug formulations
GB9404248D0 (en) Pharmaceutical formulations
ZA975883B (en) High dose liposomal aerosol formulations
GB9713149D0 (en) Pharmaceutical formulations
HUP0002691A3 (en) Medicinal aerosol products containing ciclesonide
PH31337A (en) Aerosol drug formulations containing polyglycolyzed glyceride.
ZA978303B (en) Medicinal aerosol formulations
IL112897A0 (en) Aerosol drug formulations containing vitamin e
ZA939195B (en) Stabilized medicinal aerosol solution formulations
CY2293B1 (en) Slow-release pharmaceutical formulations containing mizolastin
ZA96392B (en) Pharmaceutical formulations
GB9413542D0 (en) Pharmaceutical formulations
ZA9510754B (en) Aerosol drug formulations
GB9500978D0 (en) Pharmaceutical formulations
ZA976038B (en) Medicinal aerosol solution formulation
GB9408161D0 (en) Pharmaceutical formulations
GB9417953D0 (en) Pharmaceutical formulations
ZA953239B (en) Pharmaceutical formulations
GB9408151D0 (en) Pharmaceutical formulations